Companies Dominating the Necrotizing Ulcerative Gingivitis (NUG) Treatment Landscape
- Novartis International AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Sanofi S.A.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Otsuka Pharmaceutical Co., Ltd.
- Abbott Laboratories
- Eli Lilly and Company
- Hindustan Antibiotics Limited
Browse Key Market Insights with Data Illustration:
In the News
-
Sanofi S.A. declared an agreement with Septodont to divest a portfolio of the four dental care brands which include Ultracain, Rodogyl, Birodogyl, and Dontisolon, and medical devices. The portfolio contains medicines that are useful for both during and after dental operations.
-
U.S. Food and Drug Administration recalled a GUM PerioSheild, an oral health rinse of SUNSTAR as it was found contaminated with Burkholderia cepacian microorganisms.
